Biochemistry and Cell Biology D r a f t 2 Abstract Na + /H + exchanger isoform one (NHE1) is a mammalian plasma membrane protein that removes intracellular protons, thereby elevating intracellular pH (pH i ). NHE1 uses the energy of allowing an extracellular sodium down its gradient into cells, to remove 1 intracellular proton. The ubiquitous protein has several important physiological and pathological influences on mammalian cells as a result of its activity. The three dimensional structure of human NHE1 (hNHE1) is not known. Here, we modeled NHE1 based on the structure of MjNhaP1 of Methanocaldoccocus jannaschii in combination with biochemical surface accessibility data. hNHE1 contained 12 transmembrane segments including a characteristic Na + /H + antiporter fold of two transmembrane (TM) segments with a helix-extended region-helix conformation, crossing each other within the membrane. Amino acids 363-410 mapped principally to the extracellular surface as an extracellular loop (EL5). A large preponderance of amino acids shown to be surface accessible by biochemical experiments, mapped near to, or on, the extracellular surface. Docking of Na + /H + exchanger inhibitors to the extracellular surface suggested that inhibitor binding on an extracellular site is made up from several amino acids of different regions of the protein. The results present a novel testable, three-dimensional model illustrating NHE1 structure and accounting for experimental biochemical data.
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Introduction
Membranes are key to cellular function. They separate cells from the extracellular environment and allow cells to maintain intracellular compartments of specific content.
The plasma membrane of eukaryotic cells provides a barrier to ions permitting, for example, a relatively low intracellular sodium level and a high intracellular potassium relative to the extracellular milieu of mammalian cells. However, at the same time the plasma membrane restricts the removal of cations such as protons, which accumulate as a result of cellular metabolism. One protein that removes intracellular protons, and thereby elevates intracellular pH (pH i ) is the mammalian Na + /H + exchanger isoform one (NHE1).
NHE1 is an 815 amino acid plasma membrane protein ubiquitous in mammalian cells. It consists of a membrane domain of about 500 amino acids and an internal cytosolic regulatory domain (Fig. 1A ). NHE1 allows an extracellular sodium down its gradient into the cell and removes 1 intracellular proton. It thus maintains and elevates pH i while protecting cells from metabolism-induced acidification. NHE1 also responds actively to osmotic stress, thereby aiding in regulation of cell volume (Fliegel 2005; HendusAltenburger et al. 2014) . There are ten isoforms of Na + /H + exchangers that are different gene products. Isoform one, the ubiquitous NHE1, has several important physiological and pathological influences on mammalian cells as a result of its activity (Fliegel 1999; Fliegel et al. 1993; Fliegel et al. 1991; Lee et al. 2013a; Lee et al. 2008; Orlowski 2004; Orlowski et al. 1992; Takaichi et al. 1992) . In myocardial disease, elevated NHE1 activity acts as a trigger in both heart hypertrophy and ischemia reperfusion damage (Karmazyn 2013; Karmazyn et al. 1999) . NHE1 is also important in breast cancer, where D r a f t elevated activity can trigger metastasis (Amith and Fliegel 2016, 2017; Reshkin et al. 2014) . In animal models NHE1 inhibitors have demonstrated cardioprotective properties during ischemia reperfusion treatment episodes in the myocardium (Karmazyn 2013). In addition, NHE1 inhibition has been shown to suppress metastasis of breast cancer cells (Amith et al. 2016 ). There has therefore been a great deal of interest in the development of clinically useful NHE inhibitors and though the concept of NHE inhibitors as a therapeutic agent remains sound, off target actions of one type of inhibitor prevented successful outcomes in a clinical trial (Karmazyn 2013) . The hNHE1 protein is 815 amino acids long. The N-terminal 500 amino acids form the membrane transport domain while the C-terminal balance, forms a regulatory domain that modulates activity of the membrane domain (Lee et al. 2013a ).
Given that NHE1 plays an important role in human pathology and physiology, there has been a great deal of interest in determining the structure of the protein, both to determine its mechanism of transport, and to facilitate the development of clinically useful inhibitors. This manuscript describes developments in characterization of the structure of the NHE1 protein, from initial topology models to more recent modeling. We also present a new model of the mammalian hNHE1 protein, based on a combination of biochemical experiments and molecular modeling, and based on the recently deduced . These cross to make the NhaA fold. EcNhaA was also found to be a dimer of two 12 transmembrane helices per protomer with both N-and C-terminal cytoplasmic tails. It had a dimerization or scaffolding subdomain and a 6-helix bundle cylindrical transport subdomain (Hunte et al. 2005; Padan 2014 ). The "EcNhaA fold" (Padan 2014) contributes to the cation binding site and allows for rapid conformational changes that occur in transport. This catalytic region is in the middle of membrane. The antiparallel unfolded regions lie mid membrane between the helical regions. Where these unfolded regions cross each other, the helices surrounding the unfolded regions have a charge imparted from the helix dipoles mid membrane. This charge is neutralized by a charged polar amino acid within the membrane. The unfolded region of TM4 undergoes conformational changes with varying physiological pH and several of the conserved and functionally important residues of TM4 have been suggested to line the cationic passage channel, according to results of mutagenesis experiments (Rimon et al. 2012) . EcNhaA is active at alkaline pH (>7.5) to extrude one Na + in exchange for two H + 's. Clusters of titratable groups near the cytoplasmic funnel entrance of the antiporter may be part of the pH sensor (Olkhova et al. 2006 ) altering activity in response to pH. Another suggestion for the mechanisms of NhaA activation is that it involves a net charge switch of a pH sensor at the entrance of the cytoplasmic funnel and opening of a hydrophobic gate at the end of the funnel (Huang et al. 2016 ).
D r a f t
The NhaA fold is present in TthNapA (Lee et al. 2013b ), MjNhaP1 (Goswami et al. 2011 , and PaNhaP (Wohlert et al. 2014) . They have an additional TM helix N-terminal to the fold but have discontinuous helices 5 and 12, which correspond to 4 and 11 of
EcNhaA (Wohlert et al. 2014) . EcNhaA is a dimer. There are dimer contacts with extracellular beta strands and TM 1, TM 9, TM 6 and TM 7. Helices 6 and 7 form an alpha hairpin at the dimer interface (Padan et al. 2015) . In EcNhaA, a beta sheet on the periplasmic side of the membrane is also important in dimerization (Rimon et al. 2007 ).
MjNhaP1 is a dimer like NhaA but the dimer contacts are different. The two peptides are held together by tight helix-helix interactions across an extensive, probably hydrophobic, contact surface at the dimer interface (Goswami et al. 2011 ).
Topology of Human NHE1
The topology of the hNHE1 isoform of the Na + /H + exchanger has been the subject of some debate. The first comprehensive model based on biochemical analysis was that of Wakabayashi (Wakabayashi et al. 2000) . They did a thorough analysis using cysteinescanning accessibility and suggested a 12 transmembrane segment model. Of note, TM1
was amino acids 15-36 with an N-terminal that was cytosolic. It was followed by a large extracellular loop of about 70 amino acids. Additionally, amino acids 363-410 where thought to form a membrane associated segment, extracellular loop (EL) 5 which was preceded by TM9 (amino acids 341-362) and followed by TM10 (aa 411-432). TM 4 and TM11 were amino acids 154-176 and 449-471 respectively.
Later an alternative 3D model was proposed which was based on homology modeling with EcNhaA (Landau et al. 2007) . This model was similar to that of Wakabayashi and had 12 transmembrane regions but it was suggested that amino acids 1-125 were removed by cleavage. TM9 of (Wakabayashi et al. 2000) was reassigned as two short helices denoted TM7 and TM8 and re-entrant segment EL5 was reassigned as TM9 (amino acids 374-398). The last three transmembrane segments were the same in both models.
Our own (Liu et al. 2015) follow up work to these two studies suggested that the essential features of the Wakabayashi model were correct. We examined the cell surface accessibility of amino acids in the proposed first extracellular loop (amino acids 36-106).
A fully active cysteine free NHE1 protein was made and we used cysteine scanning mutagenesis and MTSET labeling combined with cell surface biotinylation of this protein to determine accessibility of residues mutated to cysteine. Results showed that amino acids within this region occurred in the mature protein that was present on the extracellular surface. Additionally, by using a combination of site-specific mutagenesis and cell surface labeling, we showed that NHE1 protein with the Asn75 glycosylation site, was present on the cell surface. Using the same techniques we also examined surface accessibility of the downstream amino acids of the contentious sequence amino acids 363-410. We (Liu et al. 2015) found amino acids 366, 369, 377, 401 and 402 are accessible from the extracellular surface, which agreed with the earlier results which used similar techniques and showed that 10 other amino acids in this segment are accessible extracellularly (Wakabayashi et al. 2000) . Another study (Nygaard et al. 2011 ) attempted to make a three dimensional model of hNHE1 threaded on the structure of NhaA. They attempted to assign comparable roles for Asp172 and Arg425 with the important functional residues of Nha, Asp133 and Lys300. Recently however, another report (Calinescu et al. 2017) showed that mutation of Lys300 of EcNhaA to several amino acids did not prevent electrogenic transport. And while it was suggested that mutation of these human residues should cause severe disruption of catalytic activity, mutation of Asp172 to Cys decreased activity mostly due to effects on reduced protein expression and targeting (Slepkov et al. 2005 ) and mutation of Asp172 to Asn only had a minor effect on NHE1 activity (Slepkov et al. 2007 ). This does not agree with the proposed role of Asp172 in screening a helix dipole. Their model did, however, predict that amino acids 363-410 are on the extracellular surface of the protein.
The development of new and improved inhibitors against hNHE1 can be facilitated by knowledge of the details of the atomic structure of the protein. However, obtaining the atomic structure of the entire mammalian NHE1 protein remains a challenge as yet unmet. On the other hand, computationally predicted models can still provide useful D r a f t information when the atomic structure is not available (Franca 2015) . While this approach has validity, we suggest that structural modeling should take into account empirically determined biochemical data, when available, rather than being based solely on computer modeling that are untested. E. coli NhaA is only 15% identical and 31% similar to hNHE1 and among other new Na + /H + exchanger structures elucidated, the sequence of Methanoccocus jannaschii (Goswami et al. 2011 ) is more similar to hNHE1
with 20% identity and 38% similarity. Additionally, both hNHE1 and MjNhaP1 show similar pH profiles for activity being activated by decreases in pH i (Hellmer et al. 2002) while that of E. coli is quite different from hNHE1 (Dutta and Fliegel 2018) . Recently, we predicted the structure of the plasma membrane Na + /H + antiporter for plant and yeast proteins, using a procedure that is based on an inclusive sequence alignment (Dutta and Fliegel 2018; Dutta et al. 2017; Ullah et al. 2016 ). Here we take a similar approach to build a hNHE1 structure based on MjNhaP1.
Methods
Building a human NHE1 model
Alignment
Human NHE1 sequence shows 20% sequence identity with MjNhaP1 in the membrane domain, higher than that of E. coli NhaA that is 15% identical. Therefore, MjNhaP1 D r a f t (PDB 4CZB) was used as a template to build the hNHE1 model. Multiple and pairwise sequence alignment was done as described earlier (Dutta and Fliegel 2018) and is shown in Fig. 1B . Briefly, the MAFFT server (Katoh and Standley 2013) was used for multiple and pairwise sequence alignment. Secondary structure prediction was done using the PSIPRED server (Buchan et al. 2013) . Transmembrane segment assignment was performed using TMHMM (Moller et al. 2001 ) and the TMpred server (Hofmann and Stoffel 1993) . In the alignment, we included only amino acids 96 to 520 of hNHE1 for a pairwise sequence alignment with amino acids 1-415 MjNhaP1. These residues contain the entire membrane domain of hNHE1 except for the first TM segment (TM1) and the first extracellular loop (EL1). TM segment predictions of hNHE1 were compared with the known secondary structure elements of MjNhaP1 structure (Paulino and Kuhlbrandt 2014) . The alignment of TM9 and the EL5 region was manually edited based on their predicted secondary structure, NMR structural data (Reddy et al. 2008 ) and amino acid accessibility data (Liu et al. 2015; Wakabayashi et al. 2000) .
Three Dimensional Modeling
To obtain a three-dimensional structure of the hNHE1 protein a model was built using Because there is no known structural template for EL1 (amino acids 35-95) and TM1, we incorporated TM1 (amino acids 12-34) separately into the model. The structure of TM1
(12-34) was obtained from a previously published hNHE1 model (Nygaard et al. 2011) and submitted to the HADDOCK server (van Zundert et al., 2016) which contains protein-protein docking software. As the NHE1 protein is known to be a dimer (Fafournoux et al. 1994; Hisamitsu et al. 2006; Moncoq et al. 2008) , the relative position of TM1 on the dimer interface of the NHE1 model was also predicted using HADDOCK (van Zundert et al. 2016 ) with the assumption made that TM1 should be present at the dimerization interface. TM1 has earlier been shown to be present at the dimerization interface in all Na + /H + antiporter structures reported (Hunte et al. 2005; Lee et al. 2013b; Paulino and Kuhlbrandt 2014; Wohlert et al. 2014 ). The second assumption was that D r a f t 13 TM1 should be in proximity to TM2. Which is also typical of the previously reported NHE structures. With these two assumptions hydrophobic residues from TM1 (Leu20, Ala24, Val31) and TM2 (Leu107, Leu114) were defined as "active residues" that can take part in TM1-TM2 interactions. Several potential interacting clusters were obtained from the HADDOCK analysis. However, the docking output of TM1 on the dimer interface was chosen based on two criteria. One, was the orientation of the helix; the Nterminal of the first helix should be located on the same, cytosolic side as the C-terminal of the protein. The second criterion was the selection of the populated cluster of TM1 at the dimer interface involving the most hydrophobic interactions, with buried surface area.
Between two potential positions the one with the highest HADDOCK score (-76 ± 4.2) was used further. The entire TM1-docked NHE1 structure was checked manually for any potential clashes and the Ramachandran plot improved using COOT (Emsley et al. 2010).
The structure was refined using the ModRefiner server (Xu and Zhang 2011) . Finally, the quality of the model was checked using the software RAMPAGE (Lovell et al. 2003 ).
The final model contains 93.7% favored regions, 5.6% allowed region, and 0.7% disallowed region in Ramachandran Plot.
Docking of NHE1 Inhibitors
To explore the hNHE1 inhibitor binding site we docked hNHE1 inhibitors computationally to the NHE1 model structure. 
Results and Discussion
NHE1 and MjNhaP1 Alignment
Here we aligned amino acids 96-520 of hNHE1 with amino acids 1-415 of MjNhaP1 as described above. Human NHE1 sequence shows more (20%) sequence identity with MjNhaP1 in the membrane domain, in comparison with E. coli NhaA (15% sequence identity). Residues 96-520 of hNHE1 do not contain TM1 and EL1. In the multiple sequence alignment (Fig. 1B) and its mutation compromises activity. A motif, TDPV, contains a critical hydroxyl on the Thr (which is sometimes a Ser) and a critical Pro. In the pair alignment it is evident that most of these motifs critical in activity of the Na + /H + antiporters are conserved. For example, the TDPV motifs of TM6 (TM5 of MjNhaP1), the "ND" motifs of TM7 (TM8 of MjNhaP1) and "GLRG" motifs of TM11 (TM-12 of MjNhaP1)(Dutta and Fliegel 2018) are aligned and mostly conserved. In fact, overall, the only poor alignment was found across TM-9, which is followed by the membrane reentrant loop EL5 (Liu et al. 2015; Wakabayashi et al. 2000) .
Model Description
For three dimensional modeling of hNHE1 protein a model was built using MODELLER (Fig. 2) of the NHE1 membrane domain contains twelve transmembrane helices with both cytoplasmic N-and C-termini. The twelve TM spans are Arg14-Arg33 (TM1),
Val99-Val121 (TM2), Glu131 to Leu141 (TM3), Phe155 to Phe182 (TM4), Leu186 to Cys212 (TM5), Asn227 to Glu248 (TM6), Glu253 to Val272 (TM7), Gly287 to Gly313 (TM8), Leu336 to Met354 (TM9), Ser416 to Thr433 (TM10), Lys447 to Leu468 (TM11), and finally Phe480 to Met497 (TM12). Fig. 2A , B, D illustrate lateral views of the model and Fig. 2C a view from the cytoplasmic side.
TM1 and extracellular loop 1 (EL1)
The process above so far describes hNHE1 modeling of TM2-12. The N-terminal of TM1 of hNHE1 is cytoplasmic. TM1, although predicated to be a signal sequence, remains attached to the mature protein (Fafournoux et al. 1994; Liu et al. 2015 ). As noted above, TM1 modeling was from Nygaard et al. 2011 (Nygaard et al. 2011 ) and docked independently. Therefore it was docked separately using the HADDOCK protein-protein docking server. Although, HADDOCK was designed for aqueous phase proteins, it has been used for membrane proteins with the primary prerequisite being the definition the binding site (Kaczor et al. 2013; Rashid and Kuyucak 2012) . EL1 joins TM1 with TM2 and possess one N-linked site and possibly O-linked glycosylation sites (Counillon et al. 1994; Haworth et al. 1993 ). TM1 and EL1 could not be modeled based D r a f t on MjNhaP1 as it does not align with the protein (Fig. 1) . TM1 showed mostly hydrophobic interactions with TM2 (Fig. 2C ).
TM4
Several residues of TM4 of NHE1: Phe162, Leu163, Phe167, and Gly164 are regarded as critical for inhibitor sensitivity (Counillon et al. 1997; Counillon et al. 1993b; Pedersen et al. 2007; Touret et al. 2001) . The NMR structure of a peptide of TM4 showed only a partly helical conformation (Slepkov et al. 2005) . Our results here suggest that TM4 is a helix followed by an unwound region, that is followed by a helix (Fig. 2C, E) . The unwound region consists of the sequence 165LLPPIIL171. In comparison with MjNhaP1
( Fig. 1) hNHE1 has an extra Pro residue (Pro168) in this segment which can account for the extended conformation (Slepkov et al. 2007) . TM4 is associated with the TM6 and TM11. Spin labeling Ala173Cys of TM4 and Ile461Cys of TM11 suggested an approximate distance of 15Å between these two residues (Nygaard et al. 2011 ). In our model we found a distance of 9.5Å between two Cα the differences could be due to a bias created by using MjNhaP1 as a template or different conformations of the protein. The template MjNhaP1 structure was determined at pH 8, that may be responsible for the conformation that is reflected in our model. The predicted structure of TM4 that we found is similar to that obtained by examining the structure of a peptide of TM4 (Slepkov et al. 2005) (Fig. 3A) .
TM6 and TM7
D r a f t
In the model, TM7 is a continuous helix whereas TM6 is a discontinuous helix and both are packed closely in presence of other helical segments (Fig. 2C) . This model structure closely resembles an NMR structure of a peptide of TM6-TM7 published earlier (Alves et al. 2014) . Analysis of these two TM segments structure (Alves et al. 2014) also
showed that there was a close interaction between Val242 and Phe260 which is also found in our structure (7.7Å C α distance). The RMSD between the modeled TM6-TM7 and the NMR structure (PDB 2MDF) of TM6-TM7 is 4.7A over 318 atoms. Plasma membrane Na + /H + antiporters have a "TDPV" [(V/T)DPV] motif present that has a role in activity of the protein (Dutta and Fliegel 2018). In TM6, this is present in the discontinuous region in the model structure (Fig. 2E) . A similar discontinuity is present in the equivalent helix of SpNHE1 (Ullah et al. 2013) . A peptide of TM6-7 was examined earlier by NMR. It has the same general structure, with TM6 having a discontinuous region (Alves et al. 2014) (Fig. 3B ).
TM9
Leu336 to Met354 make up TM9 in the model as a continuous helix (Fig. 2D) .
Assignment of these residues as a helix has been contentious in the past with one model assign them as a helix (Wakabayashi et al. 2000) and another suggesting that they form two separate TM segments (TM7 and TM8) (Landau et al. 2007 ). This region is weakly conserved among Na + /H + antiporters (Dutta and Fliegel 2018) and the corresponding region in NhaA of E. coli is located at the dimer interface (Padan et al. 2015 
TM11
In our model, TM11 is a discontinuous helix (Fig. 2C-E ). An NMR structure of a peptide of hNHE1 TM11 (Fig. 3D) for other Na + /H + exchangers. It is arranged such that TM2-TM3-TM4 and TM8-TM-9 are intertwined to make the dimerization domain whereas TM5-TM6-TM-7 and TM10-TM11-TM12 form the metal transportation domain (Fig. 2C,D) . TM5-TM6-TM-7 and TM10-TM11-TM12 are inverted relative to each other.
Other Considerations
There are several striking differences in this model from the existing models of hNHE1 Here we show that while there is such a fold (Fig. 2E ) interestingly, it is made up of TM6 (227-248) and TM11 (Lys447 to Leu468).
TM4 (155 to 182) is also a discontinuous helix, but does not interact with TM11 to make a typical fold. TM4, while still being a discontinuous helix, is near the NhaA fold but the N-terminal half of the helix extends upward and possibly out of the membrane domain.
The suggestion that TM6 is part of the critical fold is supported by results of sequence alignment (Dutta and Fliegel 2018) . Additionally, we earlier showed that TM6 is a discontinuous pore lining helix (Tzeng et al. 2011 ).
Docking of Na
+ /H + Exchanger Inhibitors
Docking results identified three putative EIPA interacting sites with relatively close affinities. Position 1 (Fig. 1S, Table 1S ) was the most favorable position with an affinity D r a f t of -6.4 kcal/mol. It was located in close proximity of the residues of EL5 (Trp386, Ser387, Ser388, Val389), TM9 (Leu336, Tyr339, Met340, Leu343) and TM8 (Gly305, Val306, Gly309, and Tyr312). At position 2 (Fig. 2S ) (affinity -6.1 kcal/mol) EIPA is within interacting distance of TM2 (Lys116), TM4 (Pro178), EL5 (Phe395, Leu398, Gly399), TM6 (Asp238, Val240, Leu243), and the residues of N-terminal of TM3 (Val129, Pro130, Glu131). The third EIPA interacting position (Fig. 3 , -5.9 kcal/mol) involves the residues from TM6 (Leu228, Leu229), EL4 (Val272, Leu273, Tyr274, His275), and EL5 (Lys379, Ala380, Tyr381), Leu465 (TM11) and Pro475 (EL6)). In all cases EL5 was involved in the interaction between EIPA and NHE1. (Similar results were obtained with amiloride, HMA and HOE694 ( Supplementary Fig. 3 -5.) Table 1S lists the amino acids in close proximity with the various compounds.
Position1 and position 2 are at the dimeric scaffolding domain whereas position 3 is located at the extracellular side of the interface between scaffolding domain and the transportation domain. Because NHE1 inhibitors can cause complete inhibition of the protein, we reasoned that position 3 is the mostly likely physiological binding site, despite have a slightly lower affinity than that of position one and two (Fig. 4) .
Supporting this idea, is the suggestion that amiloride based inhibitors act through inhibition of the extracellular accessible Na + binding site because the tri-hydrated Na + ion is nearly identical in structure to the guanidinium ion of amiloride (Lang 2003) .
When mutated, residues of TM4 and His349 of TM9 affect the efficacy of NHE1
inhibitors (Counillon et al. 1993a; Counillon et al. 1997; Lee et al. 2009; Wang et al. D r a f t 24 1995; Yun et al. 1993 ). We did not see any interaction of EIPA with the TM4 segment 160 VFFLFLLPPIIL 171 or with His349 of TM9. The closest distance from TM4 was with Pro168 which was 6.5 A from EIPA. However, it has not been shown that EIPA directly binds to this region. In fact, mutations in a quite a large number of residues in varied transmembrane segments affect inhibitor potency (Ding et al. 2006; Jinadasa et al. 2015) .
Some improve and some decrease inhibitor efficacy. It therefore seems likely that these mutations may have subtle effects on the conformation of the protein, thus altering the inhibitor-binding site.
Summary
We present a three-dimensional model of hNHE1. The model takes into account empirically determined biochemical data on surface accessibility of the protein in combination with molecular modeling and is based on the structure of MjNhaP1, that is more similar to hNHE1 than NhaA. In this model, TM6 and TM11 form a Na 109x174mm (300 x 300 DPI)
